Stocktoria
Zentalis Pharmaceuticals, Inc. ZNTL
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-04-03
Zentalis Pharmaceuticals, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,818,546 | $19.7M | 6.7% |
| TWO SIGMA INVESTMENTS, LP | 3,024,936 | $14.7M | 4.21% |
| CITADEL ADVISORS LLC | 2,337,803 | $11.3M | 3.25% |
| RENAISSANCE TECHNOLOGIES LLC | 1,609,078 | $7.8M | 2.24% |
| MILLENNIUM MANAGEMENT LLC | 664,281 | $3.2M | 0.92% |
| D. E. Shaw & Co., Inc. | 546,566 | $2.7M | 0.76% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.